liberDi’s Game-Changing System for People Requiring Dialysis

The Opportunity
million ESRD patients worldwide
CAGR for ESRD in next 5 years
billion Medicare spending on ESRD (U.S.)
of Medicare budget for 1% (ESRD patients) of general patient population
[Source: Jenny Blair, Holding Out for Home Hemodialisys: Still-Modest Market Promises Bigger Growth, Medtech Insight; 15-Sep-2017]
What Is End-Stage Renal Disease (ESRD) and How Is It Treated?

ESRD is defined as the drop in kidney function to less than 10% of normal. According to the American Kidney Fund, it means the kidneys “have stopped working well enough for you to survive” without treatment. Typically, treatment involves either a kidney transplant or dialysis.

Generally, there are two types of dialysis: hemodialysis (HD) and peritoneal dialysis (PD).

  • Hemodialysis typically uses a hemodialyzer (artificial kidney) to remove and circulate elements from the blood. The process is performed in three times per week in three- to five-hour sessions at a dialysis center.
  • Alternatively, dialysis can be performed daily at home using the peritoneal membrane (the membrane surrounding the abdominal organs) that acts as a blood filter. At-home peritoneal dialysis offers significant benefits: better outcomes, improved quality of life, and lower healthcare costs.

Current PD systems are bulky, suffer from complex setup procedures and a complicated regimen, and may also increase the risk of peritonitis. This discourages physicians from recommending — and people from choosing — PD. Read more about ESRD.

At liberDi, we believe that people with ESRD deserve an easy-to-use dialysis system for improved treatment and quality of life.

The liberDi Peritoneal Dialysis System

liberDi’s home peritoneal dialysis (PD) system is the easy to use, portable, smart system that enables PD exchanges anywhere or anytime. The liberDi system overcomes the main challenges of current PD solutions by providing —

  • simple setup,
  • “active” peritonitis protection, and
  • ability to accurately monitor compliance and treatment outcome.